|
|
Semler Scientific inc (SMLR) |
|
Price: $27.4600
$0.00 
0.000%
|
| Day's High:
| $28.4079
| Week Perf:
| 7.18 %
|
| Day's Low: |
$ 27.09 |
30 Day Perf: |
5.94 % |
| Volume (M): |
194 |
52 Wk High: |
$ 53.38 |
| Volume (M$): |
$ 5,338 |
52 Wk Avg: |
$33.63 |
| Open: |
$28.06 |
52 Wk Low: |
$20.88 |
|
|
| Market Capitalization (Millions $) |
214 |
| Shares
Outstanding (Millions) |
8 |
| Employees |
32 |
| Revenues (TTM) (Millions $) |
62 |
| Net Income (TTM) (Millions $) |
16 |
| Cash Flow (TTM) (Millions $) |
-32 |
| Capital Exp. (TTM) (Millions $) |
0 |
Semler Scientific Inc
Semler Scientific Inc. is a medical device company that specializes in developing and commercializing technology solutions for the early detection and prevention of chronic diseases. The company's flagship product is the CardioHealth Station, which is a non-invasive diagnostic device used to measure arterial stiffness and assess cardiovascular health. This device provides valuable information to healthcare professionals for early intervention and personalized treatment recommendations. Semler Scientific aims to improve patient outcomes and reduce healthcare costs by promoting prevention and proactive care through their innovative technology solutions.
Company Address: 2340-2348 Walsh Avenue, Suite 2344 Santa Clara 95051 CA
Company Phone Number: 774-4211 Stock Exchange / Ticker: NASDAQ SMLR
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Semler Scientific Inc
Semler Scientific Inc: Navigating a Tough Quarter but Still Holding Strong
As I delve into the financial results for Semler Scientific Inc for the second quarter of 2024, I can?t help but feel a mix of concern and cautious optimism. The stark contrast between this year?s figures and those of the previous year reveals significant challenges that the company is facing?but also hints at the resilience that investors seem to be recognizing.
In the three months leading up to June 30, 2024, Semler Scientific reported earnings of $0.00 per share, a sharp decline from the $0.75 per share recorded during the same quarter last year. When measured against the previous quarter?s $0.78 per share, this marks a troubling trend. The company has certainly stumbled?revenue eroded by 22.25% to $14.47 million from $18.61 million year-over-year, and there was also a sequential decline of 9.04%?from $15.90 million in the previous quarter.
|
| Semler Scientific Inc
Semler Scientific Inc, a company in the Medical Equipment & Supplies industry, recently released their earnings report for the first quarter of 2024. The report showed an impressive increase in earnings of 23.81% per share compared to the same period last year. The company earned $0.78 per share, up from $0.63 a year ago. This growth is also significant when compared to the previous financial reporting period, as earnings grew by 39.95% from $0.56 per share.
However, the news wasn't all positive for Semler Scientific Inc. The company experienced a decline in revenue of -12.65% to $15.90 million from $18.21 million in the corresponding period a year ago. Despite this decrease, there was sequential revenue growth of 5.619% from $15.06 million.
|
| Semler Scientific Inc
Semler Scientific Inc (SMLR) has been on a phenomenal growth trajectory, as evidenced by their recent financial results for the fiscal interval ending December 31, 2023. The company has seen a remarkable improvement in their earnings per share, with a 33.61% increase to $0.56. This impressive growth has also been reflected in their revenue, which surged by 9.148% to $15.06 million compared to $13.80 million in the prior year.
What sets Semler Scientific Inc apart from its industry peers is its ability to outperform on the revenue front. While the rest of the Medical Equipment & Supplies industry saw a 6.68% increase in revenue during the same reporting period, Semler Scientific Inc managed to achieve a much higher growth rate. Additionally, the company's net income saw a significant increase of 31.25% to $4.221 million, showing strong profitability and financial health.
|
| Semler Scientific Inc
Semler Scientific Inc, a prominent player in the Medical Equipment & Supplies industry, has released its financial results for the July to September 30, 2023 fiscal period. The company witnessed impressive revenue growth, improved profitability, and increased net income compared to the same period last year. This article aims to delve into the financial figures, interpret the data, and contextualize Semler Scientific Inc's performance within the industry.
Key Points:
1. Revenue:
- Semler Scientific Inc reported revenue of $16.32 million for the July to September 30, 2023 fiscal period, reflecting a YoY increase of 16.153%. However, the company experienced a QoQ decline of -12.303%.
- Comparatively, the rest of the Medical Equipment & Supplies industry saw a revenue rise of 4.83% during the same period, highlighting Semler's outperformance in the sector.
|
| Semler Scientific Inc
Semler Scientific Inc. recently released its second quarter financial results for 2023, and on the surface, the numbers seem impressive. The company reported a substantial revenue increase of 25.472% to $18.61 million and a profit per share surge of 47.06% to $0.75 per share compared to the same period last year. This certainly outpaces its sector peers, which only showed a 3.97% revenue growth.
However, upon closer analysis, there are several red flags that suggest a bearish outlook for Semler Scientific Inc. For one, while the company's revenue and profit per share may have seen significant increases, these numbers do not necessarily tell the whole story. Sequentially, the company only saw a modest EPS growth of 19.05% from the previous quarter, and revenue only advanced by 2.192%. This indicates a potential slowdown in growth, which could be problematic for investors.
|
| Per Share |
Current |
| Earnings (TTM) |
2.05 $ |
| Revenues (TTM) |
7.92 $
|
| Cash Flow (TTM) |
- |
| Cash |
0.94 $
|
| Book Value |
10.06 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
2.05 $
|
| Revenues (TTM) |
7.92 $ |
| Cash Flow (TTM) |
- |
| Cash |
0.94 $
|
| Book Value |
10.06 $ |
| Dividend (TTM) |
0 $ |
|
|
|
|
